InvestorsHub Logo

Sax

Followers 11
Posts 1640
Boards Moderated 0
Alias Born 06/20/2011

Sax

Re: RedShoulder post# 23946

Tuesday, 09/30/2014 3:10:54 PM

Tuesday, September 30, 2014 3:10:54 PM

Post# of 40315

The latest small sale of Petrozene was $33. Now think about that, it is not enough Petrozene to do any job. IMO that small sample was probably used for laboratory testing by a major company with a laboratory testing capabilities for petroleum and additives.


A reasonable assumption. I'm totally on board here.

Unlike some here I took that small Petrozene sale as a positive. Because IMO was used for 'testing' for possible large scale commercial applications to solve several significant problems in the storage and transportation of crude.


Yes, the small Petrozene sale could have been a positive.

However, the previous sales were all significant enough to be part of an actual application. And that's going back to Q3 of 2013 or earlier.

THOSE customers have decided they don't need the product any longer. They bought several barrels and decided it didn't do what they wanted, was too expensive for what it did, or was so good at what it did that they didn't need to buy any more. (If the last reason, FSNR should add more tank bottoms to the formulation, so that it's not as good.)

Small initial sales are good. Loss of past large sales are bad.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.